Business
Acutus Medical Reports Full Year 2024 Financial Results
CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024. Recent Highlights: 2024 Revenue from Continuing Operations of $20.2 million grew 181% year-over-year, from $7.2 million last year.Operating loss for continuing operations was $0.1 million, compared to 11.7 million last year.Recorded $10.8 million in gain on sale of business, an increase of 19% compared to last year.Cash, cash equivale
About this update from Acutus Medical Inc.
[{"type":"image","alt":"Acutus Medical, Inc.","displaySize":"","headline":null,"caption":"Acutus Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":69,"url":"https://media.zenfs.com/en/globenewswire.com/a49c9aafa5c35ff72955cd8fc3797275"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ziVzyk4IR9PhizP0RRM01w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/a49c9aafa5c35ff72955cd8fc3797275","width":300,"height":69}},"lazy":false},{"type":"text","content":"CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024.","length":163,"tagName":"p"},{"type":"text","content":"Recent Highlights:","length":18,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"2024 Revenue from Continuing Operations of $20.2 million grew 181% year-over-year, from $7.2 million last year.","length":111,"tagName":"p"}]},{"val":[{"type":"text","content":"Operating loss for continuing operations was $0.1 million, compared to 11.7 million last year.","length":94,"tagName":"p"}]},{"val":[{"type":"text","content":"Recorded $10.8 million in gain on sale of business, an increase of 19% compared to last year.","length":93,"tagName":"p"}]},{"val":[{"type":"text","content":"Cash, cash equivalents, marketable securities and restricted cash were $14.0 million as of December 31, 2024.","length":109,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":407,"olType":false},{"type":"text","content":"Full Year 2024 Financial ResultsRevenue from Continuing Operations was $20.2 million for 2024, an increase of 181% compared to $7.2 million in 2023.","length":149,"tagName":"p"},{"type":"text","content":"Gross margin on a GAAP basis for continuing operations was 5% for 2024 compared to negative 44% for 2023. The improvement was driven by higher production volumes related to left-heart access manufacturing and reduced manufacturing overhead expenses.","length":249,"tagName":"p"},{"type":"text","content":"Operating expenses for continuing operations on a GAAP basis was $1.1 million for 2024 compared to Operating expenses of $8.6 million last year. The decrease in operating expenses from reduced discretionary spend under this new business model.","length":243,"tagName":"p"},{"type":...